BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 29362937)

  • 1. Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment.
    Lee HW; Moon SH; Kim MH; Cho DH; Jun JH; Nam K; Song TJ; Park DH; Lee SS; Seo DW; Lee SK
    J Gastroenterol; 2018 Aug; 53(8):967-977. PubMed ID: 29362937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term and long-term outcomes of autoimmune pancreatitis.
    Takuma K; Kamisawa T; Tabata T; Inaba Y; Egawa N; Igarashi Y
    Eur J Gastroenterol Hepatol; 2011 Feb; 23(2):146-52. PubMed ID: 21287714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of autoimmune pancreatitis after oral prednisolone therapy.
    Nishino T; Toki F; Oyama H; Shimizu K; Shiratori K
    Intern Med; 2006; 45(8):497-501. PubMed ID: 16702740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of Long-term Maintenance Steroid Therapy Cessation in Patients With Autoimmune Pancreatitis: A Prospective Study.
    Hirano K; Tada M; Isayama H; Sasahira N; Umefune G; Akiyama D; Watanabe T; Saito T; Takagi K; Takahara N; Hamada T; Mizuno S; Miyabayashi K; Mohri D; Kogure H; Yamamoto N; Nakai Y; Arizumi T; Toda N; Koike K
    J Clin Gastroenterol; 2016 Apr; 50(4):331-7. PubMed ID: 26565969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis.
    Hart PA; Kamisawa T; Brugge WR; Chung JB; Culver EL; Czakó L; Frulloni L; Go VL; Gress TM; Kim MH; Kawa S; Lee KT; Lerch MM; Liao WC; Löhr M; Okazaki K; Ryu JK; Schleinitz N; Shimizu K; Shimosegawa T; Soetikno R; Webster G; Yadav D; Zen Y; Chari ST
    Gut; 2013 Dec; 62(12):1771-6. PubMed ID: 23232048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis.
    Sandanayake NS; Church NI; Chapman MH; Johnson GJ; Dhar DK; Amin Z; Deheragoda MG; Novelli M; Winstanley A; Rodriguez-Justo M; Hatfield AR; Pereira SP; Webster GJ
    Clin Gastroenterol Hepatol; 2009 Oct; 7(10):1089-96. PubMed ID: 19345283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appropriate steroid therapy for autoimmune pancreatitis based on long-term outcome.
    Kamisawa T; Okamoto A; Wakabayashi T; Watanabe H; Sawabu N
    Scand J Gastroenterol; 2008; 43(5):609-13. PubMed ID: 18415756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction and Management for Relapse of Type 1 Autoimmune Pancreatitis After Initial Steroid Treatment: A Long-Term Follow-up From China.
    Xin L; Meng QQ; Hu LH; Lin H; Pan J; Hao L; Liu PP; Qian W; Wang LW; Li ZS
    Pancreas; 2018 Oct; 47(9):1110-1114. PubMed ID: 30142120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relapsing autoimmune pancreatitis type 1: case report].
    Ondrejková A; Kianička B; Nechutová H; Hruška L; Novotný I; Souček M
    Vnitr Lek; 2017; 63(4):277-283. PubMed ID: 28520452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between pancreatic atrophy after steroid therapy and diabetes mellitus in patients with autoimmune pancreatitis.
    Masuda A; Shiomi H; Matsuda T; Takenaka M; Arisaka Y; Azuma T; Kutsumi H
    Pancreatology; 2014; 14(5):361-5. PubMed ID: 25278305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose maintenance steroid treatment could reduce the relapse rate in patients with type 1 autoimmune pancreatitis: a long-term Japanese multicenter analysis of 510 patients.
    Kubota K; Kamisawa T; Okazaki K; Kawa S; Hirano K; Hirooka Y; Uchida K; Shiomi H; Ohara H; Shimizu K; Arakura N; Kanno A; Sakagami J; Itoi T; Ito T; Ueki T; Nishino T; Inui K; Mizuno N; Yoshida H; Sugiyama M; Iwasaki E; Irisawa A; Shimosegawa T; Takeyama Y; Chiba T
    J Gastroenterol; 2017 Aug; 52(8):955-964. PubMed ID: 28062947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substitution of aspartic acid at position 57 of the DQbeta1 affects relapse of autoimmune pancreatitis.
    Park DH; Kim MH; Oh HB; Kwon OJ; Choi YJ; Lee SS; Lee TY; Seo DW; Lee SK
    Gastroenterology; 2008 Feb; 134(2):440-6. PubMed ID: 18155707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International consensus for the treatment of autoimmune pancreatitis.
    Okazaki K; Chari ST; Frulloni L; Lerch MM; Kamisawa T; Kawa S; Kim MH; Lévy P; Masamune A; Webster G; Shimosegawa T
    Pancreatology; 2017; 17(1):1-6. PubMed ID: 28027896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management strategies for autoimmune pancreatitis.
    Kamisawa T; Takuma K; Hara S; Tabata T; Kuruma S; Inaba Y; Gopalakrishna R; Egawa N; Itokawa F; Itoi T
    Expert Opin Pharmacother; 2011 Oct; 12(14):2149-59. PubMed ID: 21711086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors predictive of relapse and spontaneous remission of autoimmune pancreatitis patients treated/not treated with corticosteroids.
    Kubota K; Watanabe S; Uchiyama T; Kato S; Sekino Y; Suzuki K; Mawatari H; Iida H; Endo H; Fujita K; Yoneda M; Takahashi H; Kirikoshi H; Kobayashi N; Saito S; Sugimori K; Hisatomi K; Matsuhashi N; Sato H; Tanida E; Sakaguchi T; Fujisawa N; Nakajima A
    J Gastroenterol; 2011 Jun; 46(6):834-42. PubMed ID: 21491208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune Pancreatitis - A Riddle Wrapped in an Enigma.
    Webster GJ
    Dig Dis; 2016; 34(5):532-9. PubMed ID: 27333053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis.
    Kubota K; Iida H; Fujisawa T; Yoneda M; Inamori M; Abe Y; Kirikoshi H; Saito S; Ohshiro H; Kakuta Y; Nakajima A
    Gastrointest Endosc; 2007 Dec; 66(6):1142-51. PubMed ID: 18061714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy.
    Ghazale A; Chari ST; Zhang L; Smyrk TC; Takahashi N; Levy MJ; Topazian MD; Clain JE; Pearson RK; Petersen BT; Vege SS; Lindor K; Farnell MB
    Gastroenterology; 2008 Mar; 134(3):706-15. PubMed ID: 18222442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreaticobiliary involvement in treated type 1 autoimmune pancreatitis: Imaging pattern and risk factors for disease relapse.
    Zhu L; Xue HD; Zhang W; Wang Q; Tan B; Lai YM; Zheng WY; Asbach P; Hamm B; Denecke T; Jin ZY
    Eur J Radiol; 2019 Nov; 120():108673. PubMed ID: 31550640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis, treatment and long-term outcome of autoimmune pancreatitis in Sweden.
    Vujasinovic M; Valente R; Maier P; von Beckerath V; Haas SL; Arnelo U; Del Chiaro M; Kartalis N; Pozzi-Mucelli RM; Fernandez-Moro C; Verbeke CS; Yu J; Ye W; Löhr JM
    Pancreatology; 2018 Dec; 18(8):900-904. PubMed ID: 30236651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.